Novartis | NOVN - PE Price to Earnings

Stock Price
118.88
Daily Change
-0.40 -0.34%
Monthly
4.65%
Yearly
22.77%
Q1 Forecast
111.83

Novartis reported $15.74 in PE Price to Earnings for its fiscal quarter ending in September of 2025.





Pe Change Date
AbbVie USD 24.03 86.23 Dec/2025
Alcon AG USD 34.4 4.64 Sep/2025
Almirall EUR 79.13 5.18 Jun/2025
Amgen USD 9.49 3.02 Sep/2025
AstraZeneca USD 21.49 1.46 Sep/2025
Bayer EUR 5.93 0.68 Sep/2025
Biogen USD 9.38 3.02 Sep/2025
Bristol-Myers Squibb USD 9.28 1.04 Dec/2025
Eli Lilly USD 40.21 9.66 Dec/2025
Fresenius EUR 14.54 8.28 Sep/2025
Fresenius Medical Care EUR 10.57 0.65 Sep/2025
Galapagos EUR 53.92 0 Mar/2025
Genmab DKK 12.75 0.62 Sep/2025
Gilead Sciences USD 15.72 0.32 Sep/2025
GlaxoSmithKline GBP 11.15 0.29 Dec/2025
GRIFOLS EUR 16.81 28.19 Sep/2025
Hikma Pharmaceutical USD 14.14 5.42 Jun/2025
J&J USD 23.62 0.86 Dec/2025
Lonza CHF 67.52 12.2 Jun/2024
Merck EUR 13.37 0.13 Sep/2025
Merck USD 8.84 0.26 Sep/2025
Novartis USD 15.74 0.15 Sep/2025
Novartis USD 16.05 2.92 Sep/2025
Novo Nordisk DKK 12.78 0.01 Dec/2025
Orion EUR 26.11 4.52 Sep/2025
Pfizer USD 9.3 1.57 Sep/2025
Philips EUR 20.02 2.22 Sep/2025
Recordati EUR 25.3 1.41 Sep/2025
Regeneron Pharmaceuticals USD 18.11 2.91 Dec/2025
Roche Holding CHF 16.09 3.51 Dec/2025
Sanofi EUR 11.99 1.58 Dec/2025
UCB EUR 35.22 3.9 Jun/2025